Clin2
NCT05480150Possibly a fitRecruiting

Study of brain and mood in people with depression or bipolar disorder

Major Depressive DisorderBipolar Disorder, MixedAffective; Disorder, Organic

Treatments studied

Part of Mental health clinical trials.

This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
16 years to 65 years
Study type
Interventional

Who can take part

  • Ages 16 to 65, and both biological parents are Han nationality
  • A clinician diagnosed you with a depressive episode from DSM-5 major depressive disorder or bipolar disorder
  • You have not taken mood/psychiatric medicines (like antidepressants, antipsychotics, or mood stabilizers) in the past month
  • You have not taken immune-related medicines in the past month, and no recent infections of the lungs/urinary tract/digestive system
  • No history of schizophrenia-spectrum disorders, dementia, or significant memory/thinking problems
  • You can take part safely in MRI scans (no MRI contraindications) and can follow instructions with a guardian if needed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05866575Recruiting
Brain-modeling trial to predict depression treatment response

This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.

La Tronche, Isère
NCT05017311Recruiting· Phase 4
Testing a depression medication plan using symptom predictions

This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.

Calgary, Alberta
NCT05004987Recruiting· Phase 4
Study brain and blood changes in older adults with depression

This study looks at how a brain protein linked to Alzheimer’s disease changes over time in older adults who have major depression but no major memory problems. It involves brain scans, blood and urine tests, and a spinal fluid sample to better understand the connection between depression and brain aging.

New York, New York
NCT07654348Not yet recruiting· Phase 2
Testing a therapy for bipolar II depression

This trial tests if a type of talk therapy (IPSRT) can help people with bipolar II disorder who are currently depressed. Participants must have irregular daily rhythms and be off psychiatric medications for at least 4 weeks.

Hangzhou, Zhejiang
NCT05901571Not yet recruiting
Acupuncture plus escitalopram for major depression

This study tests whether adding acupuncture to escitalopram (an antidepressant) helps people with major depression feel better. It will also compare how the treatment is tolerated and whether depressive symptoms improve.

Shanghai, Shanghai Municipality
NCT06828887Recruiting· Phase 2
Testing LV232 capsules for major depression

This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.

Shanghai

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.